Languages Available
 
C

PT. Kimia Farma (Persero) Tbk [KAEF]   IDR 3.090  +40 (1,31%)


Loading...
KAEF IDR 3.090  +40 (1,31%)
Last Update 20 March 2019 04:00 PM
Open
IDR 3.050
Prev Close
IDR 3.050
Offer
IDR 3.100
Bid
IDR 3.090
Day Low
IDR 3.000
Day High
IDR 3.160
Volume
6.438 Lots (643.800 Shares)
Transaction Value (IDR)
2.003,61 M
Frequency
371 (Times)
EPS (IDR)
54,08
PE Ratio (ttm)
57,13 Times
Market Cap. (IDR)
17.161.860,00 M
Market Cap. Rank in Industry
#2 of 12 Companies in Pharmaceuticals
Market Cap. Rank in All Companies
#66 of 650 Companies
F
Net Foreign

This section of IDNFinancials requires you to sign up as a premium member of IDNFinancials.

Please check our pricing page to see all of our features.
O
Overview


PT. Kimia Farma (Persero) Tbk (KAEF) is an integrated Healthcare company. The company is engaged in in producing, processing, marketing, and distributing chemical, pharmaceutical, biologic, and other materials in Indonesia.

Subsidiary Affiliation
 
Company Name
Percentage
1.
Kimia Farma Dawaa Co Ltd
60,00 %
2.
PT Kimia Farma Trading & Distribution
99,99 %
3.
PT. Kimia Farma Apotek
99,99 %
4.
PT. Kimia Farma Sungwun Pharmacopia
75,00 %
5.
PT. Sinkona Indonesia Lestari
51,00 %
I
IPO
IPO Date04 July 2001
Offering Shares500.000.000
Company Listing5.054.000.000
Total List Shares5.554.000.000
Percentage9,00 %
Offering PriceRp 200
Fund RaisedRp 100.000.000.000
Securities Administration BureauPT. Datindo Entrycom
Lead UnderwriterPT. Danareksa Sekuritas
Listing BoardMain
No IPO bonds found
No IPO rights issue found
D
Dividend

This section of IDNFinancials requires you to sign up as a premium member of IDNFinancials.

Please check our pricing page to see all of our features.
G
Management
Commissioners
-
President Commissioner
Untung Suseno Sutarjo
Commissioner
Chrisma Aryani Albanjar
Commissioner
Muhammad Umar Fauzi
Independent Commissioner
Nurrachman
Independent Commissioner
Directors
-
President Director
Honesti Basyir
Director
Arief Pramuhanto
Director
I.G.N Suharta Wijaya
Director
Director
Verdi Budidarmo
Graph goes here...
S
Shareholders
No. Shareholder Name Number of Shares Total Paidup Capital Percentage
1. (Serie B) - Goverment of The Republic of Indonesia 4.999.999.999 IDR 499.999.999.900 90,02 %
2. (Serie B) - Public (each below 5%) 553.957.500 IDR 55.395.750.000 9,97 %
3. (Serie A) - Goverment of The Republic of Indonesia (Dwiwarna) 1 IDR 100 0,01 %
4. (Serie B) - Pujianto 42.500 IDR 4.250.000 0,00 %
V
Videos
IDNFinancials Video - Presiden Direktur Rosman dari Kimia Farma
08 April 2016 03:40 PM
JAKARTA - Manajemen perusahaan farmasi milik negara PT Kimia Farma Tbk sangat optimistis bisa meraih pertumbuhan dua digit di tahun 2016 sebagai pengganti pengembangan proyek akhir dan dukungan dari Program Kesehatan Nasional (BPJS) pemerintah...
IDNFinancials Video - Kinerja Kimia Farmasi 2014
16 April 2015 08:01 PM
JAKARTA - Menurut Direktur Keuangan PT Kimia Farma Tbk (KAEF) Farida Astuti, pertumbuhan penjualan perusahaan mencapai 4% pada tahun 2014. Untuk Harga Pokok Penjualan, efisiensi yang dilakukan sebesar 70% pada tahun 2013 dan 69,3% pada tahun 2014...
A
Announcement
Kimia Farma (Persero) distributes cash dividend amounted Rp 17.66 per share, cum April 26, 2018
2018-04-23 23:50:04
Links: [1] [2]
Kimia Farma (Persero) distributes cash dividend Rp 9.63 per share Cum April 28, 2017
2017-04-26 10:02:40
Links: [1] [2]
Kimia Farma (Persero) will hold annual shareholders' meeting on April 20, 2017
2017-03-17 14:15:47
Links: [1] [2]
Kimia Farma (Persero) pays dividend cum April 13, 2016
2016-04-11 00:33:19
Links: [1] [2]
Kimia Farma will hold annual shareholders' meeting on April 6, 2016
2016-02-22 23:50:58
Links: [1] [2] [3] [4]
S
Financial
Period Revenue Net Profit
Q3 - 2018 1.905.364 M 103.294 M
Q2 - 2018 1.911.813 M 84.786 M
Q1 - 2018 1.490.188 M 37.208 M
Q4 - 2017 1.825.504 M 134.820 M
Q3 - 2017 1.666.423 M 96.897 M
Q2 - 2017 1.437.587 M 65.879 M
Q1 - 2017 1.197.965 M 29.190 M
Q4 - 2016 1.843.760 M 93.589 M
Full financial and operational data available to our premium users. Please check our premium data introduction page to learn more about our tools.
No prospectus found